FERMENTA BIOTECH LIMITED (FERMENTA.BO)
INR 393.0
(-0.57%)
INR 393.0
(-0.57%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.05 Billion | 981.66 Million | 291.26 Million | 498.56 Million | 185.05 Million | 728.45 Million |
| Net Income | -230.59 Million | -510.75 Million | 154.47 Million | 455.06 Million | 595.26 Million | 1.17 Billion |
| Depreciation & Amortization | 247.19 Million | 282.47 Million | 255.61 Million | 203.08 Million | 149.99 Million | 118.87 Million |
| Deferred income taxes | - | -203.09 Million | -649.12 Million | -667.67 Million | -608.19 Million | -553.19 Million |
| Stock-based compensation | 1.9 Million | -10.18 Million | 26.96 Million | 59.2 Million | 55.46 Million | 5.28 Million |
| Change in working capital | 83.84 Million | 449.51 Million | -173.78 Million | -151.21 Million | -290.25 Million | -365.59 Million |
| Other non-cash items | 951.1 Million | 1.02 Billion | 677.12 Million | 600.1 Million | 282.77 Million | 348.55 Million |
| Investing Cash Flow | -154.97 Million | -580.1 Million | -283.95 Million | -463.43 Million | -482.64 Million | -995.1 Million |
| Investments in PPE | -192.07 Million | -404.89 Million | -371.28 Million | -552.7 Million | -684.69 Million | -357.71 Million |
| Acquisitions | 654 Thousand | 460 Thousand | 908 Thousand | -94.25 Million | - | 5.37 Million |
| Investment purchases | - | -163.9 Million | -5.09 Million | -21.97 Million | -30 Million | -531.46 Million |
| Sales/Maturities of investments | 40.34 Million | - | 43.89 Million | 40 Million | 270.34 Million | 3.7 Million |
| Other Investing Activities | 37.09 Million | -11.76 Million | 47.61 Million | 165.5 Million | -38.3 Million | -115 Million |
| Financing Cash Flow | -908.51 Million | -208.36 Million | -49.05 Million | 163.91 Million | -268.88 Million | 326.51 Million |
| Debt repayment | -487.63 Million | -153.57 Million | -36.71 Million | -177.45 Million | -175.33 Million | -341.03 Million |
| Dividends payments | -36.09 Million | -41.99 Million | -72.11 Million | - | -72.15 Million | -14.52 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -384.78 Million | -182.52 Million | -160.75 Million | -139.49 Million | -49.13 Million | 78.59 Million |
| Accounts receivables | -339.48 Million | 353.07 Million | -170.16 Million | 64.6 Million | 970 Thousand | 26.7 Million |
| Accounts payables | 243.18 Million | -152.71 Million | 31.29 Million | -75.25 Million | 155.46 Million | 27.98 Million |
| Inventory | 427.55 Million | 99.31 Million | 27.94 Million | -191.66 Million | -409.16 Million | -364.86 Million |
| Other working capital | -4.22 Million | 149.84 Million | -62.85 Million | 51.08 Million | -37.52 Million | -55.42 Million |
| Cash at beginning of period | 177.54 Million | 209.72 Million | 270.52 Million | 271.62 Million | 465.24 Million | 233.66 Million |
| Cash at end of period | 167.51 Million | 358.26 Million | 209.72 Million | 270.52 Million | 271.62 Million | 465.24 Million |
| Capital Expenditure | -192.07 Million | -404.89 Million | -371.28 Million | -552.7 Million | -684.69 Million | -357.71 Million |
| Effect of forex changes on cash | - | - | -1000.00 | 6.11 Million | - | 171.72 Million |
| Net cash flow / Change in cash | -10.03 Million | 148.54 Million | -60.8 Million | -1.1 Million | -193.61 Million | 231.57 Million |
| Free Cash Flow | 861.38 Million | 576.77 Million | -80.01 Million | -54.14 Million | -499.63 Million | 370.74 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -58.19 Million | -69.4 Million | -230.59 Million | 98.48 Million | -278 Million | 18.32 Million |
| Depreciation & Amortization | - | - | 247.19 Million | 63.83 Million | 59.31 Million | 59.47 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 1.9 Million | 1.9 Million | - | - | - |
| Change in working capital | - | - | 327.03 Million | - | - | - |
| Other non-cash items | 58.19 Million | 67.5 Million | 740.01 Million | -98.48 Million | 278 Million | -18.32 Million |
| Investing Cash Flow | - | - | -188.67 Million | - | - | - |
| Investments in PPE | - | - | -192.07 Million | - | - | - |
| Acquisitions | - | - | 654 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 40.34 Million | - | - | - |
| Other Investing Activities | - | - | -37.59 Million | - | - | - |
| Financing Cash Flow | - | - | -741.88 Million | - | - | - |
| Debt repayment | - | - | -692.39 Million | - | - | - |
| Dividends payments | - | - | -36.09 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -384.78 Million | - | - | - |
| Accounts receivables | - | - | -339.48 Million | - | - | - |
| Accounts payables | - | - | 243.18 Million | - | - | - |
| Inventory | - | - | 427.55 Million | - | - | - |
| Other working capital | - | - | -4.22 Million | - | - | - |
| Cash at beginning of period | - | - | 358.26 Million | 550.42 Million | 828.42 Million | 364.32 Million |
| Cash at end of period | - | - | 219.98 Million | 678.09 Million | 550.42 Million | 18.32 Million |
| Capital Expenditure | - | - | -192.07 Million | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | -138.27 Million | 127.67 Million | -278 Million | -346 Million |
| Free Cash Flow | - | - | 728.44 Million | 127.67 Million | -278 Million | 18.32 Million |
002771
CGT
0OFP
FNEC
SAUMYA
DMEHF